← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
76	Two Sigma Investments New York	$199M	-$64.8M	40	0.53%	Reduced
77	Lord, Abbett & Co Jersey City, New Jersey	$198M	-$80.6M	7	0.74%	Reduced
78	LGP Leonard Green & Partners Los Angeles, California	$198M	$0	1	4.06%	Maintained
79	Fisher Asset Management Camas, Washington	$190M	-$2.78M	5	0.11%	Reduced
80	Two Sigma Advisers New York	$189M	-$49.7M	33	0.48%	Reduced
81	Mackenzie Financial Toronto Ontario, Ontario, Canada	$188M	+$7.03M	8	0.32%	Increased
82	SEI Investments Oaks, Pennsylvania	$188M	-$12.5M	15	0.34%	Reduced
83	Capital Research Global Investors Los Angeles, California	$187M	+$31.3M	3	0.05%	Increased
84	Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts	$186M	+$107M	1	0.88%	Increased
85	Assenagon Asset Management Senningerberg, Luxembourg	$185M	+$9.62M	12	0.57%	Increased
86	Elliott Investment Management West Palm Beach, Florida	$182M	+$187M	1	1.41%	New
87	Royal Bank of Canada Toronto, Ontario, Canada	$180M	+$276K	79	0.05%	Increased
88	Macquarie Group Sydney, NSW 2000, Australia	$179M	-$10.2M	19	0.22%	Reduced
89	CCM Camber Capital Management Boston, Massachusetts	$177M	+$78.7M	3	5.83%	Increased
90	MG Meritage Group San Francisco, California	$173M	+$181M	1	4.11%	New
91	Credit Suisse Zurich, Switzerland	$170M	-$49.9M	29	0.17%	Reduced
92	Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$168M	+$17.4M	41	0.1%	Increased
93	Neuberger Berman Group New York	$168M	+$11.7M	7	0.15%	Increased
94	RSCM Rock Springs Capital Management Baltimore, Maryland	$167M	-$2.02M	9	4.48%	Reduced
95	Legal & General Group London, United Kingdom	$167M	-$8.12M	42	0.06%	Reduced
96	Citigroup New York	$165M	+$24.8M	57	0.12%	Increased
97	Montrusco Bolton Investments Montreal, Quebec, Canada	$164M	+$46.3M	1	2.39%	Increased
98	ACM Aisling Capital Management New York	$164M	$0	3	67.55%	Maintained
99	PHS PFM Health Sciences San Francisco, California	$164M	+$28M	9	7.71%	Increased
100	Bellevue Group Kuesnacht, Switzerland	$161M	-$16.2M	9	2.6%	Reduced